Mission and Values
The Knowledge Recovery Institute (KRFI) is at the forefront of pioneering drug research, particularly focusing on the therapeutic potential of natural plant-based entheogenic medicinals such as ibogaine and psychedelic medicine ie., Psilocybin, DMT, 5 Meo DMT, Peyote, and others. Through a unique Private-Public Partnership (PPP) model, and, Global Mental Health Securities - Opioid Abatement Matching Fund. KRFI is exploring innovative approaches to addressing the global opioid and substance use crisis, mental health challenges, and supporting sustainable development through indigenous knowledge and cultural practices.
Vision
KRFI envisions a world where sustainable development, causes of conflict for natural plant resource management and promoting sustainable agricultural practices and forestry management through effective Private Public sector Partnership, and collaborative foundation for global mental health, particularly in the realm of drug policy. The institute aims to create a supporting generation IP for private sector leaders who can develop innovative solutions to the challenges posed by the Opioid drug pandemic globally with a particular focus on mental health and addiction recovery.
Mission
The Knowledge Recovery Institute (KRFI) is at the forefront of pioneering drug research, particularly focusing on the therapeutic potential of natural plant-based entheogenic medicinals such as ibogaine and psychedelic medicine ie., Psilocybin, DMT, 5 Meo DMT, Peyote, and others. Through a unique Private-Public Partnership (PPP) model, and, Global Mental Health Securities - Opioid Abatement Matching Fund. KRFI is exploring innovative approaches to addressing the global opioid and substance use crisis, mental health challenges, and supporting sustainable development through indigenous knowledge and cultural practices.
Goals and 2030 Action Plan for UN Global Mental Health Security Task Force
Key Initiatives and Focus Areas
Ibogaine and Psychedelic Research
KRFI conducts clinical trial to investigate the effectiveness of ibogaine (a naturally occurring compound from the African iboga plant) and psychedelic entheogenic medicines ranging from psilocybin (the active compound in psychedelic mushrooms) in treating opioid use disorder (OUD), substance use disorders (SUD), TBI, PTSD, and Parkinson's disease, and other mental health conditions. The institute aims to provide scientific evidence for these substances' therapeutic potential through comprehensive mechanisms of action and biomarker research.
Global Collaboration for Health Equity as Human Rights
By advocating for Veterans and Tribal Health, KRFI works with indigenous communities, non governmental organizations, academia, and private sectors to ensure ethical practices in the development of plant-based drugs. This includes protecting the intellectual property (IP) and traditional knowledge of indigenous communities, while ensuring that they benefit from the commercialization of these natural medicines.
Clinical Trial Innovations
KRFI is engaged in clinical trials for its flagship products, Endabuse® and Remogen®, aimed at addressing addiction and neurological conditions. These trials will provide medical evidence for ibogaine and psilocybin treatments, paving the way for new, non-addictive therapies.
Private Public Sector Partnership for Opioid Abatement Matching Fund
(Global Menatl Health Security Fund)
KRFI is actively engaged in a strategic effort to secure State Level Ibogaine Research Bill for funding for opioid abatement treatment** Global Mental Health Security Fund is a partnership programs through PPP models for sustainable access to ibogaine and psychedelic therapies. This includes leveraging state-level funding to develop and implement evidence-based solutions for addiction and mental health treatment.
Policy Advocacy and Education
The institute focuses on policy reform and diplomatic PPP dialogue to create sustainable, globally-inclusive health frameworks. Through public educational programs and sustainable natural products resource management and building initiatives, KRFI prepares future leaders to advocate for PPP for ABS for good governance, health equity, and social justice in drug policy, with a specific emphasis on psychedelic therapeutics.
Sustainable Development through PPP for ibogaine and psychedelics
KRFI advocates for the sustainable development of natural products by working with indigenous communities in a transparent and fair sustainable partnership. The institute supports the development of supply chains for plant-based medicines, ensuring that the local communities have a direct stake in the economic benefits derived from the global demand for these therapeutics
Key Initiatives and Focus Areas
Private Sector Leadership in Access for Benefit Sharing
This program focuses on sustainable agricultural practices and partnerships between private sectors, indigenous communities, and public entities. Participants gain a deep understanding of how conservation and ethical drug development can coexist.
Opioid Abatement Matching Fund PPP Global Partnership for ABS
​A specialized program aimed at fostering natural resources conflict resolution and creating sustainable economic systems in partnership with indigenous groups and their resources.
Public Policy for Health Equity and Good Governance
This program helps policymakers and civil servants develop frameworks to ensure health equity, promote human rights, and enhance public participation in decision-making, especially in drug policy.
Private Sector Partnership Programs
KRFI's Blockchain Supply Chain Security Blockchain initiatives is a programs to ensure transparency and sustainability in the supply of psychedelic medicines, creating traceable systems from plant to patient.
Goals and 2030 Action Plan for UN Global Mental Health Security Task Force
KRFI collaborates with a wide range of international civil societies, NGOs, academic institutions, and governments to ensure the development of sustainable and ethical drug policies. The institute’s Roundtable for PPP initiative brings together diverse stakeholders to foster collaboration and drive policy reform on a global scale, particularly around psychedelic therapeutics and mental health treatments.
Knowledge Recovery Institute private public sector partnership for opioid abatement matching fund global movement for mental health security and Opioid and substance abuse recovery, working through the innovative use of natural products like ibogaine and psilocybin. Through cross-sector partnerships, policy reform, and global education, KRFI seeks to revolutionize how society approaches mental health treatment and addiction recovery, while also ensuring that indigenous knowledge and cultures benefit from the recognition and protection of their contributions to modern medicine.
Contact us with any convenient way. We are always opened for new ideas and big deeds.
E-mail: info@krfi.org
Social neworks: Linkedin | Facebook | Instagram | Twitter